CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

Volume: 22, Issue: 5
Published: Apr 6, 2018
Abstract
CGRP is a key neuropeptide in migraine pathophysiology. The blockade of the CGRP pathway at the side of the CGRP receptor of the CGRP peptide leads to the interruption of trigeminal nerve system-mediated headache syndromes such as migraine. Monoclonal antibodies (mAbs) targeting the CGRP pathway have been developed and are currently under investigation for episodic (EM) and chronic migraine (CM) prevention. Here, we report data from these...
Paper Details
Title
CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine
Published Date
Apr 6, 2018
Volume
22
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.